000			01983 a2200541 4500
005			20250516151956.0
264		0	_c20140211
008			201402s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/annrheumdis-2012-203201 _2doi
040			_aNLM _beng _cNLM
100	1		_aSieper, J
245	0	0	_aEfficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cJan 2014
300			_a101-7 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntirheumatic Agents _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEarly Diagnosis
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNaproxen _xadministration & dosage
650	0	4	_aPlacebos
650	0	4	_aSpondylarthritis _xdiagnosis
650	0	4	_aSpondylitis, Ankylosing _xdiagnosis
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aLenaerts, J
700	1		_aWollenhaupt, J
700	1		_aRudwaleit, M
700	1		_aMazurov, V I
700	1		_aMyasoutova, L
700	1		_aPark, S
700	1		_aSong, Y
700	1		_aYao, R
700	1		_aChitkara, D
700	1		_aVastesaeger, N
773	0		_tAnnals of the rheumatic diseases _gvol. 73 _gno. 1 _gp. 101-7
856	4	0	_uhttps://doi.org/10.1136/annrheumdis-2012-203201 _zAvailable from publisher's website
999			_c22771511 _d22771511